Clinical Trial Update: Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion [Phase 2]

View source ↗

Summary

Phase 2 trial of intra-arterial microplasmin for acute limb ischemia due to arterial occlusion has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb Ischemia

Drugs mentioned

• microplasmin (microplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Arterial Occlusive Diseases | Phase 2 | Status: TERMINATED